DDX41 is involved in pre-mRNA splicing and has tumour suppressor activity, with mutations in DDX41 being associated with Myelodysplastic syndromes (MDS) (Polprasert et al., 2015). Here, DDX41 is linked to myelodysplastic syndrome.